Fluorescence

Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems

Retrieved on: 
星期一, 五月 20, 2024

FREMONT, Calif., May 20, 2024 (GLOBE NEWSWIRE) -- Today Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, officially announced its Enhanced Small Particle (ESP™) Detection Option for its flagship Cytek Aurora ™ and Cytek Northern Lights ™ cell analysis systems.

Key Points: 
  • FREMONT, Calif., May 20, 2024 (GLOBE NEWSWIRE) -- Today Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, officially announced its Enhanced Small Particle (ESP™) Detection Option for its flagship Cytek Aurora ™ and Cytek Northern Lights ™ cell analysis systems.
  • With this optional upgrade, these systems show superior sensitivity and resolution of subcellular materials, including extracellular vesicles (EVs), while maintaining high resolution and high parameter capabilities for cell analysis, making them the preferred choice among researchers and clinicians.
  • Typically, flow cytometers have been unable to detect particles smaller than 500 nm, limiting their use to the study of cells and larger particles.
  • For availability details and more information on Cytek’s new ESP Detection Option on the Cytek Aurora and Northern Lights systems, please visit https://cytekbio.com/pages/esp .

American Oncology Network Advances Karyogram Segmentation and Increases the Speed to Results with New A.I. Software

Retrieved on: 
星期三, 五月 15, 2024

software HiBand v8.4 for karyogram segmentation and classification.

Key Points: 
  • software HiBand v8.4 for karyogram segmentation and classification.
  • leverages machine learning to screen chromosomes and genetic disorders in real time and then simultaneously segment and categorize them in a karyogram.
  • The process increases efficiency and allows for expedited results processing, serving as a critical support tool in patient care and treatment decision-making.
  • It has set us apart by offering patients quicker turnaround time for critical results.”
    For more information about AON, visit www.AONcology.com .

MolecuLight Clinical Research Featured at the Upcoming SAWC Spring 2024 Conference

Retrieved on: 
星期二, 五月 14, 2024

Notably, one of these posters, recognized as the top-scoring abstract, introduces an innovative upcoming device feature: thermal imaging.

Key Points: 
  • Notably, one of these posters, recognized as the top-scoring abstract, introduces an innovative upcoming device feature: thermal imaging.
  • The international conference, taking place from May 14 - 18, 2024, in Orlando, Florida, stands as one of the largest multidisciplinary meetings of wound care professionals globally.
  • In addition to the clinical posters and presentations at SAWC Spring 2024 , the MolecuLight i:X® and DX™ imaging devices will be available for demonstration in the MolecuLight booth #312 in the Exhibition Hall.
  • With unmatched clinical evidence including 95 peer-reviewed publications with over 3000 patients, they are used by leading wound care facilities globally.

MolecuLight Clinical Research Featured at the Upcoming SAWC Spring 2024 Conference

Retrieved on: 
星期二, 五月 14, 2024

TORONTO and ORLANDO, Fla., May 14, 2024 /PRNewswire/ -- - MolecuLight Inc., the pioneer in point-of-care fluorescence imaging for real-time detection of elevated bacterial loads in wounds, proudly announces the presentation of findings from multiple MolecuLight studies in nine clinical posters at the Symposium on Advanced Wound Care (SAWC) Spring 2024. These studies feature new data demonstrating enhanced diagnostics, targeted debridement, improved healing outcomes, and increased patient engagement facilitated by MolecuLight devices. Notably, one of these posters, recognized as the top-scoring abstract, introduces an innovative upcoming device feature: thermal imaging. The international conference, taking place from May 14 - 18, 2024, in Orlando, Florida, stands as one of the largest multidisciplinary meetings of wound care professionals globally.

Key Points: 
  • Notably, one of these posters, recognized as the top-scoring abstract, introduces an innovative upcoming device feature: thermal imaging.
  • The international conference, taking place from May 14 - 18, 2024, in Orlando, Florida, stands as one of the largest multidisciplinary meetings of wound care professionals globally.
  • In addition to the clinical posters and presentations at SAWC Spring 2024 , the MolecuLight i:X® and DX™ imaging devices will be available for demonstration in the MolecuLight booth #312 in the Exhibition Hall.
  • With unmatched clinical evidence including 95 peer-reviewed publications with over 3000 patients, they are used by leading wound care facilities globally.

Leading Academic Neurosurgeons Describe New NICO Myriad SPECTRA™ System as a 'Game-Changing Advancement' in Surgical Removal of High-Grade Glioma Brain Tumors

Retrieved on: 
星期五, 五月 3, 2024

New NICO SPECTRA is only hand-held technology delivering blue light closer to target to enhance tissue fluorescence.

Key Points: 
  • New NICO SPECTRA is only hand-held technology delivering blue light closer to target to enhance tissue fluorescence.
  • "Sending light deep into the brain is not easy and can make these cases extremely difficult.
  • The SPECTRA System provides illumination, resection, collection and biological preservation of tissue for the surgical removal of brain tumors and intracerebral hemorrhages using minimally invasive and open craniotomy surgical approaches.
  • Learn more about NICO technologies at NICOneuro.com ; follow us on LinkedIn and Twitter , view surgical and patient videos on YouTube .

Promising perspectives for the application of SDS Optic’s inPROBE technology platform for protein expression determination

Retrieved on: 
星期四, 四月 25, 2024

SDS Optic’s inPROBE® marks a pivotal shift in oncology towards personalized medicine, particularly in the assessment of protein expression like HER2.

Key Points: 
  • SDS Optic’s inPROBE® marks a pivotal shift in oncology towards personalized medicine, particularly in the assessment of protein expression like HER2.
  • This novel in vivo approach allows the examination with optic fiber probe directly in the patient’s body without tissue extraction.
  • These outcomes have paved the way for further research across different cancers and other diseases where protein markers are critical.
  • inPROBE® not only enhances the accuracy of cancer diagnostics and treatment but also holds potential for broader scientific and industrial applications.

New NICO Myriad SPECTRA™ System Launching at Annual Neurosurgeon Meeting in Chicago

Retrieved on: 
星期四, 四月 25, 2024

INDIANAPOLIS, April 25, 2024 /PRNewswire/ -- Medical device innovator and worldwide leader in minimally invasive neurosurgery NICO Corporation is launching its latest product innovation at next week's American Association of Neurosurgical Surgeons (AANS) Annual Scientific Meeting in Chicago, Booth #825. The NICO Myriad SPECTRA System provides the only hand-held technology delivering white light for improved tumor and clot visualization and blue light to support fluorescence-guided surgical removal of grade III and IV gliomas when used with compatible surgical microscopes. Both light sources provide directional light closer to the surgical site area of interest.

Key Points: 
  • INDIANAPOLIS, April 25, 2024 /PRNewswire/ -- Medical device innovator and worldwide leader in minimally invasive neurosurgery NICO Corporation is launching its latest product innovation at next week's American Association of Neurosurgical Surgeons (AANS) Annual Scientific Meeting in Chicago, Booth #825.
  • SPECTRA delivers white light to enhance visualization, blue light to aid fluorescence-guided removal of deadly gliomas.
  • "Surgeon workflow and clinical efficiencies are critical benchmarks in today's healthcare standards," said Jim Pearson, president & CEO of NICO.
  • Learn more about NICO technologies at NICOneuro.com ; follow us on LinkedIn and Twitter , view surgical and patient videos on YouTube .

XIMEA Releases New Ultraviolet Camera Models with Sony IMX487

Retrieved on: 
星期五, 四月 19, 2024

MUNSTER, Germany, April 19, 2024 /PRNewswire-PRWeb/ -- Within the realm of modern technology, cameras have progressed from mere devices capturing visible light to sophisticated tools divulging concealed facets of the electromagnetic spectrum.

Key Points: 
  • XIMEA expands the offer of Ultraviolet cameras with MX081 models.
  • With a spectral range extending from 200 to 400 nm, XIMEA's MX081 model of UV camera captures UV radiation with exceptional sensitivity and accuracy.
  • One of the innovations is the UV camera, delving beyond human visual perception, and unlocking a realm of information that was previously unattainable.
  • Equipped with a resolution of 8.1 megapixels (2856 x 2848 pixels), the camera delivers sharp, detailed images with precise pixel-level clarity.

Synaptive Medical Receives FDA 510(k) Clearance for Near-Infrared Fluorescence Visualization, Expanding Application of Existing Robotic Exoscope

Retrieved on: 
星期三, 三月 27, 2024

Near-Infrared fluorescence now available on Modus X robotic exoscope, complementing system’s existing advanced fluorescence capabilities

Key Points: 
  • Near-Infrared fluorescence now available on Modus X robotic exoscope, complementing system’s existing advanced fluorescence capabilities
    TORONTO, March 27, 2024 (GLOBE NEWSWIRE) -- Synaptive Medical Inc., a global med tech and technology company solving surgical, imaging and data challenges, has received 510(k) clearance from the Food and Drug Administration (FDA) for its Near-Infrared fluorescence visualization module, Modus IR, adding to the existing fluorescence offering on its 4K 3D robotic exoscope, Modus X.
  • Synaptive’s Modus X features a unique fluorescence feature, powered by customized LED lighting, that enables a live fusion of white light and fluorescence views.
  • This enables visualization of fluorescent tissue and surrounding anatomy simultaneously to provide additional anatomical context while performing complex microsurgical techniques.
  • ICG causes blood to fluoresce under infrared light and is used to aid in the visualization of vessels and blood flow.

Rapaport Press Release: Prices of Lower-Clarity Diamonds Rise in March

Retrieved on: 
星期二, 四月 2, 2024

Prices for round, 1-carat, D-H, SI diamonds increased 1.7% in March as the lower-clarity segment saw a correction after last year’s severe declines.

Key Points: 
  • Prices for round, 1-carat, D-H, SI diamonds increased 1.7% in March as the lower-clarity segment saw a correction after last year’s severe declines.
  • Diamonds with no fluorescence or black centers sold at premiums.
  • Group of Seven (G7) sanctions on Russian diamonds over 1 carat went into effect March 1.
  • Many questions about the US sanctions remain, including how the government will treat “grandfathered” diamonds.